Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatmentTomoaki Higuchi, Yasushi Kawaguchi|Arthritis Research & Therapy|2019Cited by 10
Antifibrotic effect of apremilast in systemic sclerosis dermal fibroblasts and bleomycin-induced mouse modelTomoaki Higuchi, Yasushi Kawaguchi|Scientific Reports|2023Cited by 8
Apremilast reverses the profibrotic phenotype of dermal fibroblasts derived from patients with systemic sclerosis and prevents the progression of bleomycin-induced dermal fibrosis in miceTomoaki Higuchi, Yasushi Kawaguchi|Research Square|2023Cited by 0